Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?
- PMID: 32018151
- PMCID: PMC7109519
- DOI: 10.1016/j.parkreldis.2020.01.017
Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?
Abstract
We present a case of mild, adult-onset dopa-responsive dystonia (DRD) with a heterozygous mutation in the tyrosine hydroxylase (TH) gene. We propose that this genetic state may have led to partial enzyme deficiency. Future studies should attempt to identify and characterize the phenotype of other patients with single TH variants.
Keywords: Autosomal recessive; Dopa-responsive; Dystonia; Heterozygote; Tyrosine hydroxylase.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The manuscript has not been previously published and is not under review at any other journal. No other related work is under submission elsewhere. All authors of the paper have participated to the study, revised the manuscript and approved the final version of the manuscript. There is no ghost writer. There is no financial or any other type of conflict of interest related to the manuscript.
Comment in
-
Comment on "Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?".Parkinsonism Relat Disord. 2020 May;74:81-82. doi: 10.1016/j.parkreldis.2020.03.027. Epub 2020 Apr 1. Parkinsonism Relat Disord. 2020. PMID: 32276759 No abstract available.
-
Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency? Response from the authors.Parkinsonism Relat Disord. 2020 May;74:80. doi: 10.1016/j.parkreldis.2020.03.026. Epub 2020 Apr 9. Parkinsonism Relat Disord. 2020. PMID: 32305180 No abstract available.
References
-
- Wijemanne S., Jankovic J. Dopa-responsive dystonia--clinical and genetic heterogeneity. Nat. Rev. Neurol. 2015;11(7):414–424. - PubMed
-
- Willemsen M.A., Verbeek M.M., Kamsteeg E.-J. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain: J. Neurol. 2010;133(Pt 6):1810–1822. - PubMed
-
- Furukawa Y., Kish S. Tyrosine hydroxylase deficiency.; 1993. http://www.ncbi.nlm.nih.gov/pubmed/20301610 - PubMed
-
- Yeung W.-L., Wong V.C.N., Chan K.-Y. Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency. J. Child Neurol. 2011;26(2):179–187. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
